The Chemours Company
US ˙ NYSE ˙ US1638511089

Introduction

This page provides a comprehensive analysis of the known insider trading history of David C Shelton. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David C Shelton has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CC / The Chemours Company SVP, GC & Corp. Secretary 33,868
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David C Shelton. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CC / The Chemours Company - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CC / The Chemours Company. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2019-08-05 CC Shelton David C 15,000 13.8171 15,000 13.8171 207,256 366 20.7900 104,594 50.47
2015-09-04 CC Shelton David C 5,000 9.0000 5,000 9.0000 45,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CC / The Chemours Company Insider Trades
Insider Sales CC / The Chemours Company - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CC / The Chemours Company. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2022-05-05 CC Shelton David C 83,044 39.9900 83,044 39.9900 3,320,930 144 23.9400 -1,332,856 -40.14
2022-05-05 CC Shelton David C 67,736 39.9900 67,736 39.9900 2,708,763
2017-10-13 CC Shelton David C 5,908 56.0100 5,908 56.0100 330,907
2017-10-10 CC Shelton David C 7,000 55.0000 7,000 55.0000 385,000
2017-10-10 CC Shelton David C 6,397 55.0000 6,397 55.0000 351,835
2017-10-05 CC Shelton David C 6,000 54.0000 6,000 54.0000 324,000
2017-10-05 CC Shelton David C 7,000 54.0000 7,000 54.0000 378,000
2017-10-03 CC Shelton David C 6,000 53.0000 6,000 53.0000 318,000
2017-08-31 CC Shelton David C 13,337 48.4800 13,337 48.4800 646,578
2017-08-31 CC Shelton David C 13,337 48.4800 13,337 48.4800 646,578

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CC / The Chemours Company Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David C Shelton as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-05-09 2022-05-05 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -67,736 33,868 -66.67
2022-05-09 2022-05-05 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -83,044 0 -100.00
2022-05-09 2022-05-05 4 CC Chemours Co
Common Stock
S - Sale -67,736 51,125 -56.99 39.99 -2,708,763 2,044,493
2022-05-09 2022-05-05 4 CC Chemours Co
Common Stock
M - Exercise 67,736 118,861 132.49 14.43 977,430 1,715,166
2022-05-09 2022-05-05 4 CC Chemours Co
Common Stock
S - Sale -83,044 51,125 -61.90 39.99 -3,320,930 2,044,493
2022-05-09 2022-05-05 4 CC Chemours Co
Common Stock
M - Exercise 83,044 134,169 162.43 5.40 448,438 724,513
2022-03-03 2022-03-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 38,422 38,422
2022-03-03 2022-03-01 4 CC Chemours Co
Common Stock
A - Award 3,656 50,896 7.74
2022-03-03 2022-03-01 4 CC Chemours Co
Common Stock
F - Taxes -2,722 47,240 -5.45 25.98 -70,718 1,227,298
2022-02-15 2022-02-11 4 CC Chemours Co
Common Stock
F - Taxes -2,933 66,798 -4.21 30.00 -87,990 2,003,936
2022-02-15 2022-02-11 4 CC Chemours Co
Common Stock
A - Award 8,578 69,731 14.03
2021-12-03 2021-12-02 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise X -9,886 0 -100.00
2021-12-03 2021-12-02 4 CC Chemours Co
Common Stock
S - Sale X -9,886 80,960 -10.88 29.74 -294,010 2,407,751
2021-12-03 2021-12-02 4 CC Chemours Co
Common Stock
M - Exercise X 9,886 90,846 12.21 18.45 182,397 1,676,109
2021-08-30 2021-08-30 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise X -1,065 9,886 -9.73
2021-08-30 2021-08-30 4 CC Chemours Co
Common Stock
S - Sale X -1,065 63,927 -1.64 35.00 -37,275 2,237,459
2021-08-30 2021-08-30 4 CC Chemours Co
Common Stock
M - Exercise X 1,065 64,992 1.67 18.45 19,649 1,199,110
2021-08-30 2021-08-27 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise X -8,689 10,951 -44.24
2021-08-30 2021-08-27 4 CC Chemours Co
Common Stock
S - Sale X -8,689 63,927 -11.97 35.00 -304,115 2,237,459
2021-08-30 2021-08-27 4 CC Chemours Co
Common Stock
M - Exercise X 8,689 72,616 13.59 18.45 160,312 1,339,773
2021-03-03 2021-03-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 38,854 38,854
2021-03-03 2021-03-01 4 CC Chemours Co
Common Stock
A - Award 24,780 63,701 63.67
2021-02-17 2021-02-12 4 CC Chemours Co
Common Stock
F - Taxes -762 38,921 -1.92 26.14 -19,919 1,017,397
2021-02-17 2021-02-12 4 CC Chemours Co
Common Stock
A - Award 2,031 39,683 5.39
2020-03-04 2020-03-02 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 101,604 101,604
2020-02-19 2020-02-14 4 CC Chemours Co
Common Stock
F - Taxes -5,516 109,152 -4.81 19.37 -106,845 2,114,274
2020-02-19 2020-02-14 4 CC Chemours Co
Common Stock
A - Award 16,399 114,668 16.69
2019-08-06 2019-08-05 4 CC Chemours Co
Common Stock
P - Purchase 15,000 98,269 18.01 13.82 207,256 1,357,793
2019-03-06 2019-03-05 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 26,480 26,480
2019-02-20 2019-02-15 4 CC Chemours Co
Common Stock
F - Taxes -42,384 81,631 -34.18 37.75 -1,599,996 3,081,570
2019-02-20 2019-02-15 4 CC Chemours Co
Common Stock
A - Award 97,966 124,015 376.08
2018-08-07 2018-08-04 4 CC Chemours Co
Common Stock
F - Taxes -13,566 27,687 -32.88 47.04 -638,145 1,302,396
2018-03-05 2018-03-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 16,545 16,545
2018-02-06 2018-02-04 4 CC Chemours Co
Common Stock
F - Taxes -426 41,042 -1.03 49.22 -20,968 2,020,087
2017-10-13 2017-10-13 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -5,908 0 -100.00
2017-10-13 2017-10-13 4 CC Chemours Co
Common Stock
S - Sale -5,908 41,448 -12.48 56.01 -330,907 2,321,502
2017-10-13 2017-10-13 4 CC Chemours Co
Common Stock
M - Exercise X 5,908 47,356 14.25 15.49 91,515 733,544
2017-10-12 2017-10-10 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -6,397 0 -100.00
2017-10-12 2017-10-10 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -7,000 5,908 -54.23
2017-10-12 2017-10-10 4 CC Chemours Co
Common Stock
S - Sale -6,397 41,448 -13.37 55.00 -351,835 2,279,640
2017-10-12 2017-10-10 4 CC Chemours Co
Common Stock
M - Exercise X 6,397 47,845 15.43 11.87 75,932 567,920
2017-10-12 2017-10-10 4 CC Chemours Co
Common Stock
S - Sale -7,000 41,448 -14.45 55.00 -385,000 2,279,640
2017-10-12 2017-10-10 4 CC Chemours Co
Common Stock
M - Exercise X 7,000 48,448 16.89 15.49 108,430 750,460
2017-10-05 2017-10-05 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -7,000 12,908 -35.16
2017-10-05 2017-10-05 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -6,000 6,397 -48.40
2017-10-05 2017-10-05 4 CC Chemours Co
Common Stock
S - Sale -7,000 41,448 -14.45 54.00 -378,000 2,238,192
2017-10-05 2017-10-05 4 CC Chemours Co
Common Stock
M - Exercise X 7,000 48,448 16.89 15.49 108,430 750,460
2017-10-05 2017-10-05 4 CC Chemours Co
Common Stock
S - Sale -6,000 41,448 -12.65 54.00 -324,000 2,238,192
2017-10-05 2017-10-05 4 CC Chemours Co
Common Stock
M - Exercise X 6,000 47,448 14.48 11.87 71,220 563,208
2017-10-05 2017-10-03 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -6,000 12,397 -32.61
2017-10-05 2017-10-03 4 CC Chemours Co
Common Stock
S - Sale -6,000 41,448 -12.65 53.00 -318,000 2,196,744
2017-10-05 2017-10-03 4 CC Chemours Co
Common Stock
M - Exercise X 6,000 47,448 14.48 11.87 71,220 563,208
2017-09-05 2017-08-31 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise 13,337 0 -100.00
2017-09-05 2017-08-31 4 CC Chemours Co
Common Stock
S - Sale -13,337 41,429 -24.35 48.48 -646,578 2,008,478
2017-09-05 2017-08-31 4 CC Chemours Co
Common Stock
M - Exercise 13,337 54,766 32.19 12.96 172,848 709,767
2017-09-05 2017-08-31 4/A CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -13,337 0 -100.00
2017-09-05 2017-08-31 4/A CC Chemours Co
Common Stock
S - Sale -13,337 41,429 -24.35 48.48 -646,578 2,008,478
2017-09-05 2017-08-31 4/A CC Chemours Co
Common Stock
M - Exercise X 13,337 54,766 32.19 12.96 172,848 709,767
2017-09-05 2017-08-31 4/A CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -13,337 0 -100.00
2017-09-05 2017-08-31 4/A CC Chemours Co
Common Stock
S - Sale -13,337 41,429 -24.35 48.48 -646,578 2,008,478
2017-09-05 2017-08-31 4/A CC Chemours Co
Common Stock
M - Exercise 13,337 54,766 32.19 12.96 172,848 709,767
2017-03-10 2017-03-09 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 19,788 19,788
2017-02-15 2017-02-13 4 CC Chemours Co
Common Stock
A - Award 30,596 41,378 283.77
2017-02-07 2017-02-05 4 CC Chemours Co
Common Stock
F - Taxes -721 10,781 -6.27 27.62 -19,914 297,771
2017-02-07 2017-02-04 4 CC Chemours Co
Common Stock
F - Taxes -493 11,502 -4.11 27.62 -13,617 317,685
2016-03-03 2016-03-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 83,044 83,044
2016-02-12 2016-02-06 4 CC Chemours Co
Common Stock
F - Taxes -623 12,124 -4.89 4.17 -2,598 50,557
2016-02-12 2016-02-05 4 CC Chemours Co
Common Stock
F - Taxes -662 12,747 -4.94 4.17 -2,761 53,155
2016-02-12 2016-02-04 4 CC Chemours Co
Common Stock
F - Taxes -452 13,409 -3.26 4.40 -1,989 59,000
2015-09-08 2015-09-04 4 CC Chemours Co
Common Stock
P - Purchase 5,000 13,183 61.10 9.00 45,000 118,648
2015-07-06 2015-07-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 19,640 19,640
2015-07-06 2015-07-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 19,908 19,908
2015-07-06 2015-07-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 18,397 18,397
2015-07-06 2015-07-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 13,337 13,337
2015-07-06 2015-07-01 4 CC Chemours Co
Common Stock, par value $.01
A - Award 7,623 8,183 1,361.25
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)